General management in intensive care of patient with spontaneous subarachnoid hemorrhage;Manejo general en cuidados intensivos del paciente con hemorragia subaracnoidea espontánea

Medicina Intensiva

Volumn 32, Issue 7, 2008, Pages 342-353

  Guerrero Lopez F ^a   De La Linde Valverde, C M ^a   Pino Sanchez Y F I ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Embolization therapeutic; Hydrocephalus; Intracranial aneurysm; Nimodipine; Subarachnoid hemorrhage; Ultrasonography doppler transcranial; Vasospasm intracranial

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; CLAZOSENTAN; CYCLOSPORIN; DIPYRONE; ERYTHROPOIETIN; IBUPROFEN; NICARDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; PAPAVERINE; PARALDEHYDE; PHENYTOIN; PRAVASTATIN; SIMVASTATIN; UROKINASE; VALPROIC ACID; VERAPAMIL;

BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; HEADACHE; HUMAN; INTENSIVE CARE; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

EID: 56049101667     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/S0210-5691(08)76212-0     Document Type: Article

References (79)

1. Van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249-78.
2. Wijdicks EFM, Kallmes DF, Manno EM, Fulgham JR, Piepgras DG. Subarachnoid hemorrhage: Neurointensive Care and Aneurysm Repair. Mayo Clin Proc. 2005;80:550-9.
3. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387-96.
4. Al-Shani R, White PM, Davenport RJ, Lindsay KW. Subarachnoid haemorrhage. BMJ. 2006;333:235-40.
5. Van Gijn J, Kerr RS, Rinkel GJE. Subarachnoid haemorrhage. Lancet. 2007;369:306-18.
6. De Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365-72.
7. Muñoz-Sánchez MA, García Alfaro C, Muñoz López A, Guerrero-López F, Jiménez Moragas JM, Murillo-Cabezas F, et al. Proyecto EHSA: estudio de hemorragias subaracnoideas espontáneas en Andalucía. Incidencia y resultados. Rev Neurol. 2003;36:301-6.
8. Cesarini KG, Hardemark HG, Persson L. Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period. J Neurosurg. 1999;90:664-72.
9. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660-4.
10. Stegmayr B, Eriksson M, Asplund K. Declining mortality from subarachnoid hemorrhage: changes in incidence and case fatality from 1985 through 2000. Stroke. 2004;35:2059-63.
11. King JT, Ratcheson RA. Cost and outcomes analysis. Neurosurg Clin N Am. 1998;9:629-40.
12. Bairstow P, Dodgson A, Linto J, Khangure M. Comparison of cost and outcome of endovascular and neurosurgical procedures in the treatment of ruptured intracranial aneurysms. Australasian Radiology. 2002;46:249-51.
13. Niskanen M, Koivisto T, Ronkainen A, Rinne J, Ruokonen E. Resource use after subarachnoid hemorrhage: comparison between endovascular and surgical treatment. Neurosurgery. 2004;54:1081-8.
14. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355:928-39.
15. Ellegala DB, Day AL. Ruptured cerebral aneuryms. N Engl J Med. 2005;352:121-4.
16. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36:2773-80.
17. Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN, et al. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49:607-13.
18. Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375-81.
19. Vermeulen MJ, Schull MJ. Missed diagnosis of subarachnoid hemorrhage in the emergency department. Stroke. 2007;38:1216-21.
20. Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med. 2000;342:29-36.
21. Kowalski RG, Claassen J, Kreiter KT, Bates JE, Ostapkovich ND, Connolly ES, et al. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA. 2004;291:866-9.
22. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg. 1988;68:985-6.
23. Liebenberg WA, Worth R, Firth GB, Olney J, Norris JS. Aneurysmal subarachnoid haemorrhage: guidance in making the correct diagnosis. Postgrad Med J. 2005;81:470-3.
24. Boesiger BM, Shiber JR. Subarachnoid hemorrhage diagnosis by computed tomography and lumbar puncture: are fifth generation CT scanners better at identifying subarachnoid hemorrhage? J Emerg Med. 2005;29:23-7.
25. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
26. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012-20.
27. Friedman JA, Goerss SJ, Meyer FB, Piepgras DG, Pichelmann MA, McIver JI, et al. Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans. J Neurosurg. 2002;97:401-7.
28. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery. 2006;59:21-7.
29. Wiesmann M, Mayer TE, Yousry I, Medele R, Hamann GF, Bruckmann H. Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg. 2002;96:684-9.
30. 30. Mitchell P, Wilkinson ID, Hoggard N, Paley MN, Jellinek DA, Powell T, et al. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2001;70:205-11.
31. Anderson G, Steinke DE, Petruk KC, Ashforth R, Findlay JM. Computed tomographic angiography versus digital substraction angiography for the diagnosis and early treatment of ruptured intracranial aneurysms. Neurosurgery. 1999;45:1315-22.
32. Hashimoto H, Iida JI, Hironaka Y, Okada M, Sakaki T. Use of sipral computerized tomography angiography in patients with subarachnoid hemorraghe in whom substraction angiography did not reveal cerebral aneurysms. J Neurosurg. 2000;92:278-83.
33. Chappell ET, Moure FC, Good MC. Comparison of computed tomographic angiography with digital subtraction angiography in the diagnosis of cerebral aneurysms: a meta-analysis. Neurosurgery. 2003;52:624-31.
34. Kadri S, Brunel H, Bourbotte G, Delort P, Lust S, Bonafe A. Can multislice helical computed tomography replace conventional angiography in the diagnosis of non traumatic subarachnoid hemorrhage? J Neuroradiol. 2006;33:45-50.
35. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation. A meta-analysis. Stroke. 1999;30:317-20.
36. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315-28.
37. Findlay JM and a Canadian Neurougical Society practice guidelines review group. Current management of aneurismal subarachnoid hemorrhage. Guidelines from the Canadian Neurosurgical Society. Can J Neurol Sci. 1997;24:161-70.
38. Whitfield PC, Kirkpatrick PJ. Timing of surgery for aneurysmal subarachnoid haemorrhage [Review]. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD001697.
39. Roos YBWEM, Rinkel GJE, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage [Review]. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD00145.
40. Rinkel GJE, Feigin VL, Algra A, van Gijn J. Circulatory volume expansion for aneurysmal subarachnoid hemorrhage (Review). Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD000483.
41. Van der Schaaf I, Algra A, Wermer M, Molyneux A, Clarke M, van Gijn J, et al. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhage. Cochrane Dabase of Systematic Reviews 2005, Issue 4. Art. No.: CD003085.
42. Feigin VL, Anderson N, Rinkel GJE, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage (Review). Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004583.
43. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage (Review). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006184.
44. Dorhout Mees SM, Rinkel GJE, Feigin VL, Algra A, van de Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage [Review]. Cochrane Database of Sys tematic Reviews 2007, Issue 3. Art. No.: CD000277.
45. Naval NS, Stevenes RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2006;34:511-24.
46. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247:117-21.
47. Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery. 2004;55:532-8.
48. Springborg JB, Frederiksen HJ, Eskeses V, Olsen N. Trends in monitoring patients with aneurysmal subarachnoid haemorrhage. Br J Anaesth. 2005;94:259-70.
49. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771-8.
50. Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology. 2000;54:77-82.
51. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysms Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-74.
52. Molyneux AJ, Kerr RSC, Yu LM, Clarke M, Sneade M, Yarnold JA, et al; ISAT collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809-17.
53. Todd MM, Hindman BJ, Clarke WR, Torner JC; Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135-45.
54. Lysakowski CL, Walder B, Costanza MC, Tramèr MR. Transcranial doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm. A Systematic review. Stroke. 2001;32:2292-8.
55. Lee JY, Lee MS, Whang K, Lee LM, Kim SH, Lee SS. Accuracy of transcranial doppler sonography for predicting cerebral infarction in aneurysmal subarachnoid hemorrhage. J Clin Ultrasound. 2006;34:380-4.
56. Smith M. Intensive care management of patients with subarachnoid hemorrhage. Curr Opin Anesthesiol. 2007;20:400-7.
57. Trimble JL, Kockler DR. Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Ann Pharmacother. 2007;41:2019-23.
58. Janardhan V, Biondi A, Riina HA, Sanelli PC, Stieg PE, Gobin YP. Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention and management. Neuroimag Clin N Am. 2006;16:483-96.
59. Liu-DeRyke X, Rhoney DH. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: An overview of pharmacologic management. Pharmacotherapy. 2006;26:182-203.
60. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636-42.
61. Van den Bergh WM, on behalf of the MASH Study Group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage. A randomized controlled trial. Stroke. 2005;36:1011-5.
62. Schmid-Elsaesser R, Kunz M, Zausinger S, Pruecker S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery. 2006;58:1054-65.
63. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;96:510-4.
64. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33-9.
65. Dorhout Mees SM, Rinkel GJE, Hop JW, Algra A, van Gijn J. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003;34:2285-9.
66. Van den Bergh WM; MASH Study Group (Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al). Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke. 2006;37:2326-30.
67. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593-606.
68. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2:614-21.
69. Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35:1844-51.
70. Zwienenberg-Lee M, Hartman J, Rudisill N, Muizelaar JP. Endovascular management of cerebral vasospasm. Neurosurgery. 2006;59 Suppl 3:S139-47; discussion S3-13.
71. Mueller-Kronast N, Jahromi BS. Endovascular treatment of ruptured aneurysms and vasospasm. Curr Treat Options Neurol. 2007;9:146-57.
72. Hellingman CA, van den Bergh WM, Beijer IS, van Dijk GW, Algra A, van Gijn J, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:96-9.
73. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225-32.
74. Solenski NJ, Haley C, Kassell NF, Kongable G, Germanson T, Truskowski L, et al. Medical complications of aneurysmal subarachnoid hemorraghe: a report of the multicenter, cooperative aneurysm study. Crit Care Med. 1995;23:1007-17.
75. Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832-8.
76. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617-23.
77. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: new strategies for prevention and management. Curr Opin Crit Care. 2006;12:78-84.
78. Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: Incidence, risk factors, and outcome. Crit Care Med. 2006;34:196-202.
79. Macmillan CSA, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid hemorrhage: time for active management? Intensive Care Med. 2002;28:1012-23.